FIELD: medicine; oncology.
SUBSTANCE: thoracic lymphatic duct is drained with lymph collected, incubated at temperature 37°C within 24 hours with Ronkoleukine 1 million ME (IL-2). It is followed with combined autolymphoimmunotherapy and autolymphochemotherapy.
EFFECT: stimulation ensured by generation of lymphokine-activated killers, antineoplastic cell-mediated immune response stimulating tumour lysis with low toxicity and good tolerance to chemotherapy.
3 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING LOCALLYSPREAD AND GENERALISED LUNG CANCER | 2007 |
|
RU2351346C2 |
METHOD OF TREATING LUNG CANCER | 2010 |
|
RU2463062C2 |
METHOD FOR TREATING THE CASES OF OVARIAN CARCINOMA | 2001 |
|
RU2191586C1 |
METHOD OF TREATMENT OF PATIENTS WITH LUNG CANCER | 1995 |
|
RU2123342C1 |
METHOD FOR COMPLEX THERAPY OF PULMONARY CANCER. | 2003 |
|
RU2257218C1 |
METHOD FOR TREATMENT OF RELAPSES IN ONCOGYNECOLOGICAL PATIENTS | 2005 |
|
RU2296564C2 |
METHOD FOR TREATING INOPERABLE PULMONARY CANCER | 2003 |
|
RU2257233C2 |
METHOD OF TREATING LUNG CANCER | 2011 |
|
RU2464992C1 |
METHOD TO TREAT PULMONARY CANCER | 1999 |
|
RU2184555C2 |
METHOD FOR TREATMENT OF LUNG CANCER | 2004 |
|
RU2271824C1 |
Authors
Dates
2009-03-10—Published
2007-04-17—Filed